List of works - Dara L Aisner

A 20 gene model for predicting nodal involvement in bladder cancer patients with muscle invasive tumors

scientific article

Activation of RAS family members confers resistance to ROS1 targeting drugs.

scientific article

An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer

scientific article published on 8 April 2016

An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101

scientific article

Anaplastic PXA in adults: case series with clinicopathologic and molecular features

scientific article

Atypical teratoid/rhabdoid tumor arising in a ganglioglioma: genetic characterization

scientific article

Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors

scientific article

BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation

scientific article

Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society

scientific article published on 15 April 2016

Composite pleomorphic xanthoastrocytoma-epithelioid glioneuronal tumor with BRAF V600E mutation - report of three cases

scientific article

Diagnosis of Acute Cellular Rejection and Antibody-Mediated Rejection on Lung Transplant Biopsies: A Perspective From Members of the Pulmonary Pathology Society

scientific article published on 7 November 2016

Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer

scientific article published on 20 December 2012

Do More With Less: Tips and Techniques for Maximizing Small Biopsy and Cytology Specimens for Molecular and Ancillary Testing: The University of Colorado Experience

scientific article published on 9 September 2016

Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literature

scientific article

Epithelioid GBMs show a high percentage of BRAF V600E mutation.

scientific article

Erlotinib response in an NSCLC patient with a novel compound G719D+L861R mutation in EGFR.

scientific article

HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers.

scientific article

Identifying and targeting ROS1 gene fusions in non-small cell lung cancer

scientific article

Is there clinical value to prognostic signatures in early-stage NSCLC?

scientific article

KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas

scientific article published on July 2015

Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer

scientific article

Loss of S100 antigenicity in metastatic melanoma

scientific article published on September 2005

Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status

scientific article published on 26 March 2016

Massive dissemination from spinal cord gangliogliomas negative for BRAF V600E: report of two rare adult cases.

scientific article

Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer.

scientific article

Molecular Pathology of Non-Small Cell Lung Cancer

scientific article published on 30 September 2012

Multi-Institutional FASTQ File Exchange as a Means of Proficiency Testing for Next-Generation Sequencing Bioinformatics and Variant Interpretation.

scientific article

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

scientific article published on May 2015

Native and rearranged ALK copy number and rearranged cell count in non-small cell lung cancer: implications for ALK inhibitor therapy

scientific article published on 10 September 2013

Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

scientific article published on April 2017

Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions.

scientific article published on 29 December 2016

Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer

scientific article

Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of cases

scientific article

Phase I study of oral rigosertib (ON 01910.Na), a dual inhibitor of the PI3K and Plk1 pathways, in adult patients with advanced solid malignancies

scientific article

Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society

scientific article

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer.

scientific article published on 24 August 2015

ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers.

scientific article

Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society

scientific article published on 22 June 2017

Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer

scientific article

Rociletinib in EGFR-mutated non-small-cell lung cancer

scientific article

Targeting the WNT Signaling Pathway in Cancer Therapeutics

scientific article published on 25 August 2015

Telomerase regulation: not just flipping the switch

scientific article

The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomas

scientific article published on 19 July 2013

The role of cytology specimens in molecular testing of solid tumors: techniques, limitations, and opportunities

scientific article published on June 2012

Transbronchial Lung Cryobiopsy for Interstitial Lung Disease Diagnosis: A Perspective From Members of the Pulmonary Pathology Society

scientific article published on 21 July 2016

List of works by Dara L Aisner

A 20 gene model for predicting nodal involvement in bladder cancer patients with muscle invasive tumors

Activation of RAS family members confers resistance to ROS1 targeting drugs.

An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer

An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101

Anaplastic PXA in adults: case series with clinicopathologic and molecular features

Atypical teratoid/rhabdoid tumor arising in a ganglioglioma: genetic characterization

Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors

BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation

Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society

Composite pleomorphic xanthoastrocytoma-epithelioid glioneuronal tumor with BRAF V600E mutation - report of three cases

Diagnosis of Acute Cellular Rejection and Antibody-Mediated Rejection on Lung Transplant Biopsies: A Perspective From Members of the Pulmonary Pathology Society

Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer

Do More With Less: Tips and Techniques for Maximizing Small Biopsy and Cytology Specimens for Molecular and Ancillary Testing: The University of Colorado Experience

Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literature

Epithelioid GBMs show a high percentage of BRAF V600E mutation.

Erlotinib response in an NSCLC patient with a novel compound G719D+L861R mutation in EGFR.

HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers.

Identifying and targeting ROS1 gene fusions in non-small cell lung cancer

Is there clinical value to prognostic signatures in early-stage NSCLC?

KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas

Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer

Loss of S100 antigenicity in metastatic melanoma

Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status

Massive dissemination from spinal cord gangliogliomas negative for BRAF V600E: report of two rare adult cases.

Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer.

Molecular Pathology of Non-Small Cell Lung Cancer

Multi-Institutional FASTQ File Exchange as a Means of Proficiency Testing for Next-Generation Sequencing Bioinformatics and Variant Interpretation.

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

Native and rearranged ALK copy number and rearranged cell count in non-small cell lung cancer: implications for ALK inhibitor therapy

Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions.

Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer

Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of cases

Phase I study of oral rigosertib (ON 01910.Na), a dual inhibitor of the PI3K and Plk1 pathways, in adult patients with advanced solid malignancies

Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer.

ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers.

Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society

Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer

Rociletinib in EGFR-mutated non-small-cell lung cancer

Targeting the WNT Signaling Pathway in Cancer Therapeutics

Telomerase regulation: not just flipping the switch

The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomas

The role of cytology specimens in molecular testing of solid tumors: techniques, limitations, and opportunities

Transbronchial Lung Cryobiopsy for Interstitial Lung Disease Diagnosis: A Perspective From Members of the Pulmonary Pathology Society